Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Oncology Nursing

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejon.2015.04.001PMID 25933709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flushing the Central Venous Catheter: Is Heparin Necessary?

  2014cited by this paper
• Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.

  2014cited by this paper
• Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline.

  2013cited by this paper
• Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial.

  2013influential reference
• Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation.

  2013cited by this paper
• Heparin or 0.9% sodium chloride to maintain central venous catheter patency: A randomized trial

  2012cited by this paper
• Totally Implantable Central Venous Access Ports in Patients with Cystic Fibrosis: A Multicenter Prospective Cohort Study

  2012cited by this paper
• National survey of central venous catheter flushing in the intensive care unit.

  2012cited by this paper
• Extravasation management: clinical update.

  2011influential reference
• Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.

  2010cited by this paper
• Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review.

  2009cited by this paper
• ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).

  2009cited by this paper
• The Management of Totally Implanted Venous Ports in the Ambulatory Oncologic Patient

  2009cited by this paper
• Management of totally implantable vascular access devices in patients with cystic fibrosis.

  2009cited by this paper
• Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.

  2009cited by this paper
• Initial experience with a group presentation of study results to research participants

  2008cited by this paper
• Management of venous port systems in oncology: a review of current evidence.

  2008cited by this paper
• epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England

  2007cited by this paper
• Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

  2006cited by this paper
• Guidelines for the management of intravascular catheter-related infections.

  2001cited by this paper
• Guidelines for the management of intravascular catheter-related infections.

  2001cited by this paper
• Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials

  1998cited by this paper
• Should we adjust for covariates in nonlinear regression analyses of randomized trials?

  1998cited by this paper
• Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.

  1998influential reference
• Analysis of the research about heparinized versus nonheparinized intravascular lines.

  1991cited by this paper
• A Meta‐Analysis of Effects of Heparin Flush and Saline Flush: Quality and Cost Implications

  1991cited by this paper

• Impact of Study Hypotheses on Results From Randomized Clinical Trials: Comparison Between Standard and Noninferiority Randomized Clinical Trials.

  2026cites this paper
• The Michigan Appropriateness Guide for Intravenous Catheters in Adult Patients With Cancer (MAGIC-ONC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method.

  2025cites this paper
• Comparison of the use of standard heparin and 0.9% saline as lock solution in hemodialysis catheter: Importance of closure technique

  2025cites this paper
• Saline versus heparin in the maintenance of totally implanted central venous catheter patency in Cancer patients: a systematic review

  2024cites this paper
• SOLUÇÕES SALINA E HEPARINIZADA PARA BLOQUEIO E PERMEABILIDADE DO CATETER TOTALMENTE IMPLANTADO: MELHORES EVIDÊNCIAS

  2024cites this paper
• Heparinização Versus Salinização em Catéter totalmente implantado: Revisão Integrativa

  2023cites this paper
• Spülung/Block von vollständig implantierten Gefäßkathetern mit 0,9% NaCI oder Heparin: Einfluss auf die Katheterokklusion

  2023cites this paper
• Complications and Management Strategies of Totally Implantable Venous Access Devices

  2023cites this paper
• ESPEN practical guideline: Home parenteral nutrition.

  2023cites this paper
• Transitioning from heparin to saline locks for central venous access devices in oncology: An evidence-based practice approach.

  2022cites this paper
• Transition de l’héparine au sérum physiologique pour fermer les cathéters veineux centraux en oncologie : pratique fondée sur la recherche

  2022cites this paper
• Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial

  2022cites this paper
• Heparin versus normal saline locking for prevention of occlusion, catheter-related infections and thrombosis in central venous catheter in adults: Overview of systematic reviews

  2022cites this paper
• Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

  2022cites this paper
• Implementation of an Evidence-Based Practice Change Removing Heparin From Implanted Vascular Access Devices

  2022cites this paper
• Management of Y-Site Incompatibility of Intravenous Medication: A Scoping Review

  2022influential citation
• Heparin versus 0.9% saline solution to maintain patency of totally implanted venous access ports in cancer patients: A systematic review and meta-analysis.

  2021cites this paper
• Strategies for preventing obstruction in central catheters fully implanted in oncological patients

  2020cites this paper
• Estratégias de prevenção da obstrução em cateteres centrais totalmente implantados em pacientes oncológicos

  2020cites this paper
• ESPEN guideline on home enteral nutrition.

  2020cites this paper
• Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.

  2020cites this paper
• ESPEN guideline on home parenteral nutrition.

  2020cites this paper
• Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients

  2020cites this paper
• Chinese expert consensus and practice guideline of totally implantable access port for digestive tract carcinomas

  2020cites this paper
• Prolonging the flush-lock interval of totally implantable venous access ports in patients with cancer: A systematic review and meta-analysis

  2020cites this paper
• Heparin flush vs. normal saline flush to maintain the patency of central venous catheter among adult patients: A systematic review and meta-analysis

  2019cites this paper
• Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).

  2018cites this paper
• Acute Leukemia Patients: A CLABSI Risk Special Population

  2018cites this paper
• Implanted vascular access device options: a focused review on safety and outcomes

  2018cites this paper
• Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

  2018cites this paper
• Impact of flushing with aseptic non-touch technique using pre-filled flush or manually prepared syringes on central venous catheter occlusion and bloodstream infections in pediatric hemato-oncology patients: A randomized controlled study.

  2018cites this paper
• Comparison between Saline Solution Containing Heparin versus Saline Solution in the Lock of Totally Implantable Catheters.

  2017cites this paper
• Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis

  2017influential citation
• Implementing a central venous catheter self-management education program for patients with cancer.

  2016cites this paper
• Implantable port thrombosis in cancer patients: a monocentric experience

  2016cites this paper
• The maintenance of totally implanted venous access device: When the difference is made by the nursing practice. Reply to the Letter to the Editor.

  2016cites this paper